Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Cell Biochem ; 224(1-2): 103-16, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11693187

RESUMEN

The purpose of this study was to modify the amount of 22:4 n-6, 22:5 n-6 and 20:5 n-3 in cardiac phospholipids and to evaluate the influence of these changes on the functioning of working rat hearts and mitochondrial energy metabolism under normoxic conditions and during postischemic reperfusion. The animals were fed one of these four diets: (i) 10% sunflower seed oil (SSO); (ii) 10% SSO + 1% cholesterol; (iii) 5% fish oil (FO, EPAX 3000TG, Pronova) + 5% SSO; (iv) 5% FO + 5% SSO + 1% cholesterol. Feeding n-3 PUFA decreased n-6 PUFA and increased n-3 PUFA in plasma lipids. In the phospholipids of cardiac mitochondria, this dietary modification also induced a decrease in the n-6/n-3 PUFA ratio. Cholesterol feeding induced marked hepatic steatosis (HS) characterized by the whitish appearance of the liver. It also brought about marked changes in the fatty acid composition of plasma and mitochondrial phospholipids. These changes, characterized by the impairment of deltaS- and delta6-desaturases, were more obvious in the SSO-fed rats, probably because of the presence of the precursor of the n-6 family (linoleate) in the diet whereas the FO diet contained large amounts of eicosapentaenoic and docosahexaenoic acids. In the mitochondrial phospholipids of SSO-fed rats, the (22:4 n-6 + 22:5 n-6) to 18:2 n-6 ratio was decreased by HS, without modification of the proportion of 20:4 n-6. In the mitochondrial phospholipids of FO-fed rats, the amount of 20:5 n-3 tended to be higher (+56%). Cardiac functioning was modulated by the diets. Myocardial coronary flow was enhanced by HS in the SSO-fed rats, whereas it was decreased in the FO-fed animals. The rate constant k012 representing the activity of the adenylate kinase varied in the opposite direction, suggesting that decreased ADP concentrations could cause oxygen wasting through the opening of the permeability transition pore. The recovery of the pump function tended to be increased by n-3 PUFA feeding (+22%) and HS (+45%). However, the release of ascorbyl free radical during reperfusion was not significantly modified by the diets. Conversely, energy production was increased by ischemia/reperfusion in the SSO group, whereas it was not modified in the FO group. This supports greater ischemia/reperfusion-induced calcium accumulation in the SSO groups than in the FO groups. HS did not modify the mitochondrial energy metabolism during ischemia/reperfusion. Taken together, these data suggest that HS- and n-3 PUFA-induced decrease in 22:4 and 22:5 n-6 and increase in 20:5 n-3 favor the recovery of mechanical activity during post-ischemic reperfusion.


Asunto(s)
Grasas de la Dieta/farmacología , Ácidos Grasos Insaturados/farmacología , Corazón/efectos de los fármacos , Hígado/patología , Mitocondrias Cardíacas/efectos de los fármacos , Isquemia Miocárdica/metabolismo , Daño por Reperfusión/metabolismo , Adenina/metabolismo , Animales , Aorta/efectos de los fármacos , Aorta/fisiología , Ácido Ascórbico/metabolismo , Peso Corporal/efectos de los fármacos , Gasto Cardíaco/efectos de los fármacos , Respiración de la Célula/efectos de los fármacos , Colesterol en la Dieta/farmacología , Circulación Coronaria/efectos de los fármacos , Grasas de la Dieta/sangre , Ácidos Grasos Insaturados/sangre , Aceites de Pescado/farmacología , Radicales Libres/metabolismo , Corazón/fisiología , Hígado/efectos de los fármacos , Hígado/metabolismo , Mitocondrias Cardíacas/química , Mitocondrias Cardíacas/metabolismo , Isquemia Miocárdica/patología , Tamaño de los Órganos/efectos de los fármacos , Oxígeno/farmacología , Palmitoilcarnitina/metabolismo , Fosfatos/metabolismo , Aceites de Plantas/farmacología , Ácido Pirúvico/metabolismo , Ratas , Daño por Reperfusión/patología , Aceite de Girasol
2.
Free Radic Biol Med ; 29(9): 846-57, 2000 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-11063910

RESUMEN

The contribution of lipid peroxidation to myocardial injury by free radicals (FR) is still unclear. Consequently, we examined the functional damages inflicted on cultured rat cardiomyocytes (CM) during FR stress provoked by the xanthine/xanthine oxidase system (X/XO) or by a hydroperoxidized fatty acid ((9 Z, 11 E, 13 (S), 15 Z)-13-hydroperoxyocta-decatrienoic acid; 13-HpOTrE), in order to simulate in vitro the initial phase and the propagation phase of the FR attack, respectively. Transmembrane potentials were recorded with glass microelectrodes and contractions were monitored photometrically. The EPR spectroscopy showed that X/XO produced superoxide and hydroxyl radicals during 10 min. The X/XO system altered sharply and irreversibly the spontaneous electrical and mechanical activities of the CM. However, the gas chromatographic analysis showed that these drastic functional damages were associated with comparatively moderate membrane PUFA degradation. Moreover, the EPR analysis did not reveal the production of lipid-derived FR. 13-HpOTrE induced a moderate and reversible decrease in electrical parameters, with no change in CM contractions. These results indicate that the functional consequences of FR attack are dependent on the radical species present and do not support the idea that the membrane lipid breakdown is a major factor of myocardial oxidant dysfunction.


Asunto(s)
Miocardio/metabolismo , Estrés Oxidativo , Potenciales de Acción/efectos de los fármacos , Animales , Células Cultivadas , Espectroscopía de Resonancia por Spin del Electrón , Ácidos Grasos/química , Ácidos Grasos/metabolismo , Radicales Libres/metabolismo , Corazón/efectos de los fármacos , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Contracción Miocárdica/efectos de los fármacos , Daño por Reperfusión Miocárdica/etiología , Daño por Reperfusión Miocárdica/metabolismo , Miocardio/citología , Ratas , Xantina/metabolismo , Xantina/farmacología , Xantina Oxidasa/metabolismo , Xantina Oxidasa/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA